October 28, 2015November 6, 2015

GSK’s Asthma Therapy Advair® Diskus® Shown to Be Comparably Safe

Asthma, News

GlaxoSmithKline plc (GSK) has published results from the AUSTRI (SAS115359) study designed to evaluate the safety profile of the combinatory therapy Advair® Diskus® in patients with asthma, and which showed non-inferiority against a ... Read more

July 22, 2015November 9, 2015

FDA Approves Propeller Health Mobile Platform for GlaxoSmithKline’s Diskus DPI and Boehringer’s Respimat Inhaler

COPD, News

Propeller Health, a leading mobile platform for respiratory health management that utilizes sensors, mobile apps and services to help reduce the cost of care while improving quality of life for individuals ... Read more